Literature DB >> 22041044

Sex and gender differences in non-small cell lung cancer.

Jessica S Donington1, Yolonda L Colson.   

Abstract

Historically, lung cancer has been viewed as a male disease, but during the past 50 years there has been a dramatic increase in the incidence of lung cancer in women. Lung cancer is currently the most common cause of cancer death in American women, accounting for more than one quarter of all cancer deaths. This has been attributed to a significant increase in tobacco consumption by women; however, approximately 1 in 5 women with lung cancer never smoked. As the incidence of lung cancer in women has increased, significant gender-based differences in epidemiology, biology, and treatment responses have become evident and warrant further investigation to advance the treatment of lung cancer in all patients. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22041044     DOI: 10.1053/j.semtcvs.2011.07.001

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  24 in total

1.  Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.

Authors:  Shanshan Deng; Marco Ramos-Castaneda; Walter V Velasco; Michael J Clowers; Berenice A Gutierrez; Oscar Noble; Yiping Dong; Melody Zarghooni; Lucero Alvarado; Mauricio S Caetano; Shuanying Yang; Edwin J Ostrin; Carmen Behrens; Ignacio I Wistuba; Laura P Stabile; Humam Kadara; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Carcinogenesis       Date:  2020-11-13       Impact factor: 4.944

2.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Oxidative/antioxidative enzyme-mediated antiproliferative and proapoptotic effects of the GPER1 agonist G-1 on lung cancer cells.

Authors:  Akif Hakan Kurt; Ahmet Çelik; Bekir Mehmet Kelleci
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

4.  Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.

Authors:  Vijaya Raj Bhatt; Rishi Batra; Peter T Silberstein; Fausto R Loberiza; Apar Kishor Ganti
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

5.  Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer.

Authors:  Edward B Garon; Richard J Pietras; Richard S Finn; Naeimeh Kamranpour; Sharon Pitts; Diana C Márquez-Garbán; Amrita J Desai; Judy Dering; Wylie Hosmer; Erika M von Euw; Steven M Dubinett; Dennis J Slamon
Journal:  J Thorac Oncol       Date:  2013-03       Impact factor: 15.609

6.  Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study.

Authors:  Angela Cecilia Pesatori; Michele Carugno; Dario Consonni; Neil E Caporaso; Sholom Wacholder; Margaret Tucker; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

7.  Survival in women with NSCLC: the role of reproductive history and hormone use.

Authors:  Hannah Katcoff; Angela S Wenzlaff; Ann G Schwartz
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

8.  Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race.

Authors:  Lisa D Gardner; Christopher A Loffredo PhD; Patricia Langenberg; Diane Marie St George; Janaki Deepak; Curtis C Harris; Sania Amr
Journal:  Ann Epidemiol       Date:  2018-05-07       Impact factor: 3.797

9.  Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection.

Authors:  Akram Alkrekshi; Ila Tamaskar
Journal:  Oncologist       Date:  2021-03-20

Review 10.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.